BHC - Bausch Health Companies Inc.

QQQ $ 634.74 $ 2.85 (0.45 %)

DIA $ 476.09 $ -0.78 (-0.16 %)

SPY $ 686.84 $ 0.33 (0.05 %)

TLT $ 90.87 $ -0.93 (-1.01 %)

GLD $ 363.50 $ -1.38 (-0.38 %)

Previous Close

$ 5.9

Open

$ 6.19

Bid

$ 6.23 x 4,000

Ask

$ 6.45 x 315

Day's Range

$ 5.88 - $ 6.21

52 Week Range

$ 4.25 - $ 9.85

Volume

3,712,191

Average Volume

Market Cap

2.18B

Beta (5Y Monthly)

$ 0.98

PE Ratio (TTM)

$ 22.26

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	07-30-2025	06-30-2025	10-Q
2	04-30-2025	03-31-2025	10-Q
3	02-20-2025	12-31-2024	10-K
4	10-30-2024	09-30-2024	10-Q
5	08-01-2024	06-30-2024	10-Q
6	05-02-2024	03-31-2024	10-Q
7	02-22-2024	12-31-2023	10-K
8	11-02-2023	09-30-2023	10-Q
9	08-03-2023	06-30-2023	10-Q
10	05-04-2023	03-31-2023	10-Q
11	02-23-2023	12-31-2022	10-K
12	11-03-2022	09-30-2022	10-Q
13	08-09-2022	06-30-2022	10-Q
14	05-10-2022	03-31-2022	10-Q
15	02-23-2022	12-31-2021	10-K
16	11-02-2021	09-30-2021	10-Q
17	08-03-2021	06-30-2021	10-Q
18	05-04-2021	03-31-2021	10-Q
19	02-24-2021	12-31-2020	10-K
20	11-03-2020	09-30-2020	10-Q
21	08-06-2020	06-30-2020	10-Q
22	05-07-2020	03-31-2020	10-Q
23	02-19-2020	12-31-2019	10-K
24	11-04-2019	09-30-2019	10-Q
25	08-06-2019	06-30-2019	10-Q
26	05-06-2019	03-31-2019	10-Q
27	02-20-2019	12-31-2018	10-K
28	11-06-2018	09-30-2018	10-Q
29	08-07-2018	06-30-2018	10-Q
30	05-08-2018	03-31-2018	10-Q
31	02-28-2018	12-31-2017	10-K
32	11-07-2017	09-30-2017	10-Q
33	08-08-2017	06-30-2017	10-Q
34	05-09-2017	03-31-2017	10-Q
35	03-01-2017	12-31-2016	10-K
36	11-09-2016	09-30-2016	10-Q
37	08-09-2016	06-30-2016	10-Q
38	06-07-2016	03-31-2016	10-Q
39	04-29-2016	12-31-2015	10-K
40	10-26-2015	09-30-2015	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Bausch Health Companies Q3 Adj. EPS $1.16 ...
10/29/2025 20:26:29

Bausch Health Companies (NYSE:BHC) reported quarterly earnings of $1.16 per share which beat the analyst consensus estimate of ...

Bausch Health Companies Raises FY2025 Sale...
10/29/2025 20:09:18

Bausch Health Companies (NYSE:BHC) raises FY2025 sales outlook from $10.000 billion-$10.250 billion to $10.050 billion-$10.250 ...

Earnings Scheduled For October 29, 2025
10/29/2025 11:11:56

retail-investors-top-stocks-with-earnings-this-week-sofi-apple-meta-and-more

Retail Investors' Top Stocks With Earnings...
10/27/2025 14:38:22

Investors are gearing up for a jam-packed week of earnings featuring several big tech names and retail-trader favorites.

Bausch Health Shareholders Approve Amended...
10/09/2025 11:13:43

Bausch Health's Triple-Combination Acne Ge...
08/21/2025 12:09:52

Bausch Health, Canada Inc., part of Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical comp...

A Look Into Bausch Health Companies Inc's ...
08/20/2025 18:00:30

billionaire-investor-buys-google-and-this-gold-miner-stock

Billionaire Investor Buys Google And This ...
08/16/2025 17:46:39

John Paulson's hedge fund discloses the purchase of 9,000 shares of Alphabet.

icahn-hedge-funds-q2-moves-centuri-stake-soars-jetblue-held-2-positions-exited

Icahn Hedge Fund's Q2 Moves: Centuri Stake...
08/15/2025 19:07:48

Carl Icahn's 13F shows concentrated equity book, with top 10 holdings making up 98.76%. Notable changes in non-house names ...

Paulson Capital Boosts Stake In Bausch Hea...
08/15/2025 18:40:57

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) ("Bausch Health" or the "Company") today announced that Paulso...

Carl C. Icahn Dissolves Stake In Bausch He...
08/15/2025 13:49:32

https://www.sec.gov/Archives/edgar/data/885590/000153949725002158/xslSCHEDULE_13D_X01/primary_doc.xml

12 Health Care Stocks Moving In Friday's P...
08/15/2025 12:10:02

Bausch Health To Acquire DURECT For $63M, ...
08/12/2025 20:51:09

Recent business highlights and updates:In July 2025, DURECT announced that it entered into an Agreement and Plan of Merger with...

Bausch Health Companies Q2 Adj. EPS $0.91 ...
07/30/2025 20:32:43

Bausch Health Companies (NYSE:BHC) reported quarterly earnings of $0.91 per share which missed the analyst consensus estimate o...

Bausch Health Companies Raises FY2025 Sale...
07/30/2025 20:11:58

Bausch Health Companies (NYSE:BHC) raises FY2025 sales outlook from $9.950 billion-$10.200 billion to $10.000 billion-$10.250 b...

Bausch Health Companies Q2 Sales $2.530B B...
07/30/2025 20:10:27

Bausch Health Companies (NYSE:BHC) reported quarterly sales of $2.530 billion which beat the analyst consensus estimate of $2.4...

Earnings Scheduled For July 30, 2025
07/30/2025 08:32:48

Bausch Health Companies's Earnings Outlook
07/29/2025 20:01:52

bausch-health-adds-late-stage-ready-alcohol-liver-disease-drug-candidate-in-63-million-durect-buyout

Bausch Health Adds Late-Stage Ready Alcoho...
07/29/2025 18:21:25

Bausch Health will acquire DURECT and larsucosterol, aiming for FDA approval of a first treatment for alcoholic hepatitis via P...

Reported Earlier: Bausch Health To Acquire...
07/29/2025 13:56:06

DURECT's lead asset, Larsucosterol, is an epigenetic modulator with FDA Breakthrough Therapy DesignationPotential to be the...

The Smart Money Is Buying These 10 Stocks
05/20/2025 20:50:22